Sign in

CIK 0001228627 · Non-accelerated filer<br>Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
113516358
Phone
(984) 884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,211,769
in 7 filings, $50K under 10b5-1 plans

Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-02-28 Benaim Ely Chief Medical Officer Option exercise +2,375 4,750
2019-02-28 Benaim Ely Chief Medical Officer Option exercise · Restricted Stock Units −2,375 4,750
2019-02-27 Sullivan Lara Director Grant or award · Stock Option (right to buy) +84,968 84,968

Page 15 of 15 · 283 trades